PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33583793-9	2020	TXL treatment attenuated mast cell activation and inhibited TLR4, NF-kappaB, TNF-alpha, PECAM-1 over-expression in 3 and 7 days, protected VE-cadherin and ANGPTL4 protein.	Docetaxel	0-3	toll-like receptor 4	Rattus norvegicus	60-64	
33583793-9	2020	TXL treatment attenuated mast cell activation and inhibited TLR4, NF-kappaB, TNF-alpha, PECAM-1 over-expression in 3 and 7 days, protected VE-cadherin and ANGPTL4 protein.	Docetaxel	0-3	tumor necrosis factor	Rattus norvegicus	77-86	
33583793-9	2020	TXL treatment attenuated mast cell activation and inhibited TLR4, NF-kappaB, TNF-alpha, PECAM-1 over-expression in 3 and 7 days, protected VE-cadherin and ANGPTL4 protein.	Docetaxel	0-3	platelet and endothelial cell adhesion molecule 1	Rattus norvegicus	88-95	
33583793-9	2020	TXL treatment attenuated mast cell activation and inhibited TLR4, NF-kappaB, TNF-alpha, PECAM-1 over-expression in 3 and 7 days, protected VE-cadherin and ANGPTL4 protein.	Docetaxel	0-3	cadherin 5	Rattus norvegicus	139-150	
33583793-9	2020	TXL treatment attenuated mast cell activation and inhibited TLR4, NF-kappaB, TNF-alpha, PECAM-1 over-expression in 3 and 7 days, protected VE-cadherin and ANGPTL4 protein.	Docetaxel	0-3	angiopoietin-like 4	Rattus norvegicus	155-162